Yates Clayton Clopton 4
4 · Genvor Inc · Filed Jun 23, 2025
Insider Transaction Report
Form 4
Genvor IncGNVR
Yates Clayton Clopton
Director10% Owner
Transactions
- Award
Common Stock
2025-05-08$0.25/sh+400,000$100,000→ 400,000 total(indirect: By LLC)
Footnotes (2)
- [F1]Conversion of $100,000 in accrued payables due to Dr. Yates at $0.25/share. The issuance of the 400K shares to Clayton in consideration of his conversion of $100K in accrued payables, pursuant to Dr. Yates's restructured compensation package, which permits Dr. Yates to convert amounts due to him into common stock.
- [F2]Dr. Yates is a manager of, and may therefore be deemed to be the beneficial owner of shares held in the name of, ACT Holdings, LLC.